FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in Europe

Health care startups that raised Series B in Europe

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in Europe
One-time CSV
  • 347 funded companies, 247 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~europe.csv347 rows × 18 columns
CompanyCityLast roundAmountDate
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Laza MedicalPfaffikonSeries B$160.0M2026-11-04
Sava TechnologyLondonSeries B$36.0M2026-10-09
Incepto MedicalParisSeries B$16.0M2026-09-22
Tandem HealthStockholmSeries B$100.0M2026-09-14
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
MironidGlasgowSeries B$45.9M2026-08-05

8 rows of the CSV in 5 of its 18 columns.

347
Startups
$10.3B
Total raised
25
Funded in the last 12 months
$1.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 347
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon, Switzerland Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London, United Kingdom Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
Incepto Medical Incepto Medical develops artificial intelligence software for medical imaging. Artificial intelligence Paris, France Series B $16.0M 2026-09-22 $49.2M Bpifrance, AVP, Karista +2 51 to 100 2018
Tandem Health Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. Artificial intelligence Stockholm, Sweden Series B $100.0M 2026-09-14 $159.7M Northzone, Amino Collective 101 to 250 2023
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
Qureight Qureight develops imaging technologies and analytics software for biopharmaceutical companies. Artificial intelligence Cambridge, United Kingdom Series B $20.0M 2026-07-29 $31.2M Ascension, Playfair Capital, XTX Ventures 11 to 50 2018
CroíValve CroíValve develops medical devices to treat tricuspid regurgitation. Health care Dublin, Ireland Series B $20.0M 2026-06-23 $74.7M SOSV, Enterprise Ireland, MedTech Innovator +2 11 to 50 2016
NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Vitestro Vitestro develops autonomous technology that draws blood from patients. Health care Utrecht, The Netherlands Series B $70.0M 2026-03-10 $104.3M European Innovation Council, MedTech Innovator, Invest-NL +2 51 to 100 2017
Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
Lattice Medical Lattice Medical makes 3D printed bioabsorbable medical devices for breast reconstruction. Biotech Loos, France Series B $50.0M 2025-10-24 $63.3M Bpifrance, European Innovation Council, MedTech Innovator +1 11 to 50 2017
Simple Simple is a digital health company offering AI coaching for long-term weight loss and healthy living. Artificial intelligence Limasol, Cyprus Series B $35.0M 2025-10-01 $40.0M Target Global, s16vc 101 to 250 2018
Cyted Cyted uses AI and digital pathology to improve the detection and diagnosis of diseases, including cancer. Artificial intelligence Cambridge, United Kingdom Series B $44.0M 2025-08-30 $83.4M Innovate UK, MedTech Innovator, Morningside +1 51 to 100 2018
SNIPR Biome SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. Biotech Copenhagen, Denmark Series B $40.9M 2025-08-07 $103.4M Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 11 to 50 2017
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil, Switzerland Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
TILT Biotherapeutics TILT Biotherapeutics develops therapies that enable the immune system to attack tumors. Biotech Helsinki, Finland Series B $25.3M 2025-05-13 $71.1M European Innovation Council, Business Finland, Lifeline Ventures +1 11 to 50 2013
Skin Analytics Skin Analytics makes an AI-powered medical device that screens for melanoma skin cancer. Artificial intelligence London, United Kingdom Series B $19.9M 2025-04-16 $31.0M Bethnal Green Ventures, Wavemaker 360, Hoxton Ventures +2 51 to 100 2012
Clinomic Clinomic is a medical AI company focused on critical care. Artificial intelligence Aachen, Germany Series B $25.3M 2025-04-08 $54.6M German Federal Ministry of Research, Technology and Space 51 to 100 2019
NETRI NETRI develops technologies for the pharmaceutical industry. Biotech Lyon, France Series B $5.1M 2025-02-02 $5.1M Next Innov Prize 11 to 50 2018
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel, Switzerland Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
SynOx Therapeutics SynOx Therapeutics is a biotechnology company developing treatments for diffuse tenosynovial giant cell tumors. Biotech Dublin, Ireland Series B $92.0M 2024-10-30 $245.9M Forbion Capital Partners, Gimv, Hercules Capital +2 1 to 10 2020
Aignostics Aignostics is a company that provides AI-powered pathology diagnostics for drug development and clinical research. Artificial intelligence Berlin, Germany Series B $34.0M 2024-10-29 $54.8M HTGF (High-Tech Gruenderfonds), IBB Ventures, Wellington Partners +1 101 to 250 2018
Retinai RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. Artificial intelligence Bern, Switzerland Series B $7.8M 2024-10-16 $16.8M Venture Kick, Verve Ventures, Matterwave Ventures 11 to 50 2016
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar, Switzerland Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
Vico Therapeutics Vico Therapeutics develops RNA modulating therapies. Biotech Leiden, The Netherlands Series B $12.3M 2024-06-24 $115.4M Polaris Partners, Eurazeo, EQT Life Sciences +2 11 to 50 2019
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva, Switzerland Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017

Table 1. Health care startups that raised Series B in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 347.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon, Switzerland Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
3 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
4 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
5 Tandem Health Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. Artificial intelligence Stockholm, Sweden Series B $100.0M 2026-09-14 $159.7M Northzone, Amino Collective 101 to 250 2023
6 Vitestro Vitestro develops autonomous technology that draws blood from patients. Health care Utrecht, The Netherlands Series B $70.0M 2026-03-10 $104.3M European Innovation Council, MedTech Innovator, Invest-NL +2 51 to 100 2017
7 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
8 Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
9 NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
10 Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London, United Kingdom Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016

Table 2. Health care startups that raised Series B in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 14 4%
2 Bpifrance Government investment office Maisons-alfort, France 9 3% 1 Incepto Medical
3 Venture Kick Startup incubator Schlieren, Switzerland 8 2%
4 European Innovation Council Startup accelerator Brussels, Belgium 7 2% 1 Vitestro
5 Forbion Capital Partners Private equity firm Naarden, The Netherlands 6 2%
6 Verve Ventures Venture capital firm Zug, Switzerland 6 2%
7 Sofinnova Partners Venture capital firm Paris, France 5 1% 2 T-Therapeutics, Mironid
8 Andera Partners Private equity firm Paris, France 5 1% 1 Exciva
9 Innovate UK Entrepreneurship program Swindon, United Kingdom 5 1%
10 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 5 1%
11 Unorthodox Ventures Family office Austin, United States 4 1% 1 Laza Medical
12 MedTech Innovator Startup accelerator Los Angeles, United States 4 1% 2 CroíValve, Vitestro
13 Novo Holdings Corporate venture arm Hellerup, Denmark 4 1% 1 Windward Bio
14 Bristol-Myers Squibb Venture capital firm New York, United States 4 1%
15 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 4 1%

Table 3. Health care startups that raised Series B in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 197 57% $6.6B
Software 58 17% $1.6B
Artificial intelligence 28 8% $1.2B
Hardware 15 4% $211.1M
Commerce 6 2% $8.5M
Fintech 4 1% $72.2M
Education 3 1% $284.5M
Energy 1 0% $33.9M
Cybersecurity 1 0% $25.7M

Table 4. Health care startups that raised Series B in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 347 100% $19.9M

Table 5. Health care startups that raised Series B in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 97 28%
France 52 15%
Switzerland 51 15%
Germany 50 14%
The Netherlands 25 7%
Ireland 16 5%
Belgium 12 3%
Spain 11 3%
Italy 9 3%
Denmark 8 2%
Sweden 7 2%
Finland 4 1%

Table 6. Health care startups that raised Series B in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 44 13%
Paris 18 5%
Cambridge 16 5%
Berlin 14 4%
Dublin 11 3%
Basel 8 2%
Munich 8 2%
Oxford 7 2%
Zürich 6 2%
Schlieren 5 1%
Barcelona 5 1%
Madrid 5 1%

Table 7. Health care startups that raised Series B in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 8% $293.0M
October 2026 2 8% $86.0M
September 2026 3 12% $186.8M
August 2026 3 12% $227.6M
July 2026 4 16% $123.0M
June 2026 3 12% $156.6M
May 2026 3 12% $236.6M
April 2026 1 4% $17.6M
March 2026 1 4% $70.0M
January 2026 3 12% $94.6M

Table 8. Health care startups that raised Series B in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 25 7% $1.5B
2025 32 9% $1.6B
2024 35 10% $1.4B
2023 27 8% $693.3M
2022 40 12% $1.2B
2021 35 10% $1.4B

Table 9. Health care startups that raised Series B in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 1%
2020 to 2022 24 7%
2015 to 2019 127 37%
2010 to 2014 96 28%
Before 2010 96 28%

Table 10. Health care startups that raised Series B in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 67 19%
11 to 50 165 48%
51 to 100 52 15%
101 to 250 43 12%
251 to 500 9 3%
501 to 1,000 5 1%
1,001 to 5,000 2 1%
10,001 or more 1 0%

Table 11. Health care startups that raised Series B in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Europe whose last round is Series B are on the list?
347, in the file dated 16 November 2026. 25 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 347 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in Europe: 347 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Europe

Other sectors that raised Series B in Europe

Cite: FundingWatcher, 347 health care companies in Europe whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/europe/